Skip to content

Animal Assisted Mindfulness Intervention (AAMI) for Patients With Acquired Brain Injury

Effects of an Animal Assisted Mindfulness Intervention for Patients With Acquired Brain Injury: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03729908
Acronym
AAMI
Enrollment
31
Registered
2018-11-05
Start date
2018-06-01
Completion date
2019-09-12
Last updated
2020-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Brain Injury

Brief summary

The aim of this study is to investigate the effect of an animal assisted mindfulness intervention (AAMI) on patients with acquired brain injuries on their global severity of psychological distress. In addition, the effects on the patients' symptoms of depression, anxiety, perceived stress, mood, coping and mindfulness/self-compassion will be assessed. The study experimental condition consists of 6 weeks of intervention, containing 6 different modules. In every session, an animal will be present. In the control condition, the same program and same exercises will be used without the presence of or reference to animals. Sessions take place two times a week for 6 weeks (leading up to a total of 12 experimental/control sessions), each lasting for about 60 minutes. 24 participants are planned to be included, 12 patients in each group.

Detailed description

It was estimated that a total sample of 24 participants (12 patients in each group) would provide enough power to detect a medium effect. Since we had several dropouts, two additional groups (one intervention and one control) were started. This lead to the inclusion of 31 participants with a total sample size of 25 participants finishing the program.

Interventions

BEHAVIORALAnimal assisted mindfulness based intervention

A mindfulness based intervention in the presence of an animal

A mindfulness based intervention with no reference to animals

Sponsors

Rehab Basel
CollaboratorOTHER
University of Basel
CollaboratorOTHER
University of Bern
CollaboratorOTHER
Swiss Tropical & Public Health Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients of REHAB Basel * Acquired Brain Injury (ABI); FIM (Functional Independence Measure) cut-off score defined as \> 60 * Depressive or/and anxiety symptoms * Psychological difficulties coping with the actual life situation * 18 years or older * Willing to work with therapy animals * German speaking * Willingness to participate/informed consent

Exclusion criteria

* Communication and articulation is not possible * Allergy to animals * Aversion against animals * Schizophrenic-related comorbidity * Mobilization to Therapietiergarten not possible

Design outcomes

Primary

MeasureTime frameDescription
General psychological distress11 weeksMeasured via BSI (Global Severity Index GSI). The Global Severity Index (GSI) is designed to help quantify a patient's severity-of-illness and provides a single composite score for measuring the outcome of a treatment program based on reducing symptom severity. Minimal total score = 0, maximal total score = 212 (higher values represent a worse outcome)

Secondary

MeasureTime frameDescription
Perceived Stress11 weeksMeasured via the PSS-10-D (Perceived Stress Scale - 10). The Perceived Stress Scale was developed to measure the degree to which situations in one's life are appraised as stressful. The minimal total score is 1, the maximal total score is 40. Higher values represent worse outcome.
Mindfulness11 weeksMeasured via the FFA-14 (Freiburger Fragebogen zur Achtsamkeit). Minimum total score is 0, maximum total score is 39. Higher values represent a better outcome.
Self-compassion11 weeksMeasured via SCS-D Kurzversion (Self-compassion scale - Deutsch): Minimum total score is 1, maximum total score is 60, higher values represent a better outcome.
Depression11 weeksMeasured via BDI-FS (Beck Depression Inventory - Fast Screen for Medical Clients, without somatic items). The BDI-FS is a fast screen assessment of depression for medical patients. The minimum score is 0, the maximum score is 21, higher values represent a worse outcome.
Visual Analogue Scale (VAS)11 weeksA VAS measuring motivation, emotion, cognition and attitude towards animals. The Visual Analogue Scales (VAS) provide a simple technique for measuring subjective experience and are continuous scales comprised of a horizontal line. Minimum score for each item is 0, maximum score is 160 with higher scores representing better outcomes.
Mood6 weeksMeasured via the MDBF before and after each session: Mehrdimensionaler Befindlichkeitsfragebogen. The Mehrdimensionaler Befindlichkeitsfragebogen (MDBF) is a German-language instrument to assess the 3 mood dimensions pleasant-unpleasant, awake-sleepy, calm-restless and includes 24 items. Minimum score is 4, maximum score is 20.
Coping11 weeksMeasured via Brief COPE-G: The Brief COPE (-G, German version) Inventory is a multidimensional coping inventory to assess the different ways in which people respond to stress. It measures problem-focused coping, emotion-focused coping, and dysfunctional coping. Each subscale ranges between 1 and 8 with higher values representing higher scores in the respective coping strategy.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026